RELIEF and NeuroX complete Business Combination to form MindMaze

MindMaze Therapeutics Holding SA (SIX:MMTX; previously: RELIEF THERAPEUTICS Holding SA) acquired all the shares of NeuroX Group SA against issuance of new MMTX shares to complete their business combination by way of reverse merger. The new MMTX shares started trading at the SIX on 15 December 2025.

VISCHER advised RELIEF on all Swiss legal and tax aspects of this transaction. The team was lead by Dr. Robert Bernet (Partner, Corporate/M&A and Banking & Finance) and comprised Dr. Peter Kühn (Counsel, Corporate/M&A and Banking & Finance), Thomas Steiner-Krizaj (Managing Associate, Corporate/M&A), Christian Schneiter (Managing Associate, Banking & Finance), Hannah Everett (Junior Associate, Corporate/M&A and Banking & Finance), Christoph Niederer (Partner, Tax) and Patrik Fisch (Managing Associate, Tax).

Author: Peter Kühn

Robert Bernet

Attorney at Law

• Partner

• +41 58 211 33 51
• [email protected]

Peter Kühn

Attorney at Law

• Counsel

• +41 58 211 36 07
• [email protected]

Thomas Steiner-Krizaj

Attorney at Law

• Managing Associate

• +41 58 211 36 02
• [email protected]

Christian Schneiter

Attorney at Law

• Partner

• +41 58 211 36 54
• [email protected]

Hannah Everett

Master in Law and Economics

• Junior Associate

• +41 58 211 34 95
• [email protected]

Christoph Niederer

Attorney at Law, Swiss Certified Tax Expert

• Partner

• +41 58 211 34 37
• [email protected]

Patrik Fisch

Swiss Certified Tax Expert

• Specialist

• +41 58 211 34 31
• [email protected]